"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry.
Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible
insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
There are dozens of brain training apps on the market. Regrettably, very few have any studies showing efficacy. A recent systematic review from experts at five Alzheimer’s research centers looked at 32 brain training programs, and found only seven had any studies to review showing effects in the target population of aging adults.
It is worth noting that in the U.S. and in many countries, digital pathology is still at a very early stage, compared to many other fields that were digitized 15 or 20 years ago such as radiology. There have been some barriers to the adoption of digital pathology such as regulatory challenges that are only just now being overcome. Recently, the FDA approved the use of whole slide imaging software for primary diagnostics.
We've been in Formula 1 now for 51 years. What defines our ability to compete is the fact that we have understood the need to innovate. In addition, we take an incremental rather than disruptive approach to innovation.
Our medical connectors are used on a variety of medical devices. Here in the U.S. medical devices are approved by the FDA (Food and Drug Administration) and classified into three risk categories, classes I, II and III.
Prostate cancer is the second most diagnosed cancer globally with over a million men diagnosed worldwide. We are fortunate in that better diagnostic techniques and better awareness means that men are often being diagnosed earlier, which gives them a better chance of being cured.
Illumina was founded in 1998. It was based on technology invented by Dr. David Walt that was licensed from Tufts University and formed the basis of our microarray business. The fundamental invention was a unique way to put beads in wells that were created on fiber optic bundles, with the beads being imaged through the fibers.
Life sciences is one of the Welsh Government’s nine priority sectors for the economy, in which it is supporting industry-led investment.
The Life Sciences Hub Wales, in Cardiff, was opened in July 2014 with the aim of increasing the sector’s contribution to the Welsh economy by more than £1 billion by 2022.
The silicon photomultiplier, or SiPM, is a solid state detector representing the next generation of photon counting detector that can be used in medical imaging.
Well, the central dogma of biology states that DNA makes RNA and RNA makes proteins. However, there are many different types of RNAs, and only one of them, the messenger RNA (mRNA), gives rise to proteins. Some others don't make proteins at all.
In life science labs around the world the task of concentration of a solute in a solution is commonly achieved using evaporator technology. Such technologies are also widely used in the concentration of pharmaceutical / natural product preparations using an extraction, precipitation and drying of the crude active agent protocol.
Two application areas seeing a major surge for the Multisizer are in environmental research and for optimization of recombinant protein expression in the lab. An example of the former is work published last year by researchers at the University of Aalborg in Denmark. They used the Multisizer 4e instrument to count and size pathogenic E. coli and to study the ability of another environmental organism D. magna to reduce this pathogenic E. coli strain in the environment.
Jamf’s mission is very simple: we want to help organizations succeed with Apple devices. It's a very broad mission, Apple devices are getting used increasingly more in businesses, for example healthcare providers and in a variety of other industries, such as education. Our goal is to help them succeed with Apple devices to either empower their employees, empower their teachers or students, and help IT be more effective and efficient.
Augmedix is a Google Glass-powered remote scribe service that frees doctors from 3 hours of mandated charting and documentation each day.
The global biopreservation market was valued at $2 billion in 2015 and is expected to reach $3.7B US by 2020. Z-SC1 is operating in the biopreservation equipment segment of this market, especially dealing with mechanical freezers.
The traditional device manufacturers used by doctors such as Welch Allyn, Keeler and Heine aren’t digital. It means that they have an external light source (with a battery) and are used to look into the ears but the doctors can’t capture the images.
These prosthetics are a big change from traditional models. The knees are designed with a programmable computer that is built in to the joint. This battery powered technology continuously controls both the swing and the stance phase of the prosthetic through real time data that the computer receives from its built-in sensors.
The Phenome Center Birmingham is a large, state-of-the-art, £8M metabolic phenotyping facility that has been established as part of a stratified medicine initiative led by the Medical Research Council. It is mainly located in the School of Biosciences
Prior to microvolume spectrophotometry, UV-Vis quantification of biomolecules was performed using quartz cuvettes with a 10mm pathlength. Cuvettes had a number of key limitations that made them unsuitable for the requirements of then newly emerging life science techniques such as microarrays.
Thankfully, meningitis is a rare condition. Although it can occur in anyone, it's more prevalent in babies and young children, with young people and students being the next most at risk group. In the early stages, it can be very difficult to tell meningitis apart from milder diseases, as it often resembles other common viral illnesses. Symptoms of the disease can develop very quickly.
Bruker has been involved in the Phenome Center network since its beginning. Several years ago, the whole visionary concept of a global phenome network was actually born with Professor Jeremy Nicholson and Bruker BioSpin has been part of it since the early stages.